
CAS 198480-55-6
:2-(4-Hydroxyphenyl)-3-methyl-1-[4-[2-(1-piperidinyl)ethoxy]benzyl]-1H-indol-5-ol
Description:
2-(4-Hydroxyphenyl)-3-methyl-1-[4-[2-(1-piperidinyl)ethoxy]benzyl]-1H-indol-5-ol, with the CAS number 198480-55-6, is a synthetic organic compound characterized by its complex molecular structure, which includes an indole core, hydroxyl groups, and a piperidine moiety. This compound exhibits properties typical of indole derivatives, such as potential biological activity, including interactions with various receptors or enzymes. The presence of the hydroxyl group suggests it may engage in hydrogen bonding, enhancing its solubility in polar solvents. The piperidine ring contributes to its pharmacological profile, potentially influencing its binding affinity and selectivity for biological targets. Additionally, the ethoxy and benzyl substituents may enhance lipophilicity, affecting its distribution in biological systems. Overall, this compound's unique structure may render it of interest in medicinal chemistry, particularly in the development of therapeutic agents. However, specific biological activities and applications would require further investigation through experimental studies.
Formula:C29H32N2O3
InChI:InChI=1/C29H32N2O3/c1-21-27-19-25(33)11-14-28(27)31(29(21)23-7-9-24(32)10-8-23)20-22-5-12-26(13-6-22)34-18-17-30-15-3-2-4-16-30/h5-14,19,32-33H,2-4,15-18,20H2,1H3
SMILES:Cc1c2cc(ccc2n(Cc2ccc(cc2)OCCN2CCCCC2)c1c1ccc(cc1)O)O
Synonyms:- Pipendoxifene
- Era-923
- 2-(4-hydroxyphenyl)-3-methyl-1-[4-(2-piperidin-1-ylethoxy)benzyl]-1H-indol-5-ol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Pipendoxifene
CAS:Pipendoxifene (ERA-923) is an antiestrogen that blocks ER-alpha and inhibits MCF-7 breast cancer cell growth, effective even when tamoxifen-resistant.Formula:C29H32N2O3Color and Shape:SolidMolecular weight:456.58Pipendoxifene
CAS:Controlled ProductApplications Pipendoxifene is a 2-Ph indole selective estrogen receptor modulator (SERM) that exhibits an excellent preclin. pharmacol. profile and was selected for further development as a treatment for metastatic breast cancer.
References Cotreau, M., et al.: J. Clin. Pharm., 42, 157 (2002); Greenberger, L., et al.: Clin. Cancer Res., 7, 3166 (2001)Formula:C29H32N2O3Color and Shape:NeatMolecular weight:456.58Pipendoxifene (Piperidine-D10)
CAS:Controlled ProductFormula:C29D10H22N2O3Color and Shape:NeatMolecular weight:466.638Pipendoxifene
CAS:Pipendoxifene is a structural analogue of epidermal growth factor. It has been shown to have a therapeutic effect on bowel disease by binding to the epidermal growth factor receptor (EGFR) and stimulating cellular proliferation. Pipendoxifene also inhibits the production of inflammatory cytokines, such as tumor necrosis factor-α, and is an active form of polymerase chain reaction (PCR). The monoclonal antibodies against EGFR that are used in cancer therapy can be used in conjunction with pipendoxifene to improve their efficacy. Pipendoxifene has also been shown to have beneficial effects on diabetic neuropathy, which may be due to its ability to inhibit protein kinase C activity. Pipendoxifene has been shown to bind with high affinity to the breast cancer cell surface receptors and is a potential treatment for resistant breast cancer.Formula:C29H32N2O3Purity:Min. 95%Molecular weight:456.58 g/mol



